Related Experiment Video
Updated: May 15, 2026

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Published on: September 26, 2013
Targeting IL-17 in psoriasis: from cutaneous immunobiology to clinical application
Maria-Eugenia Ariza1, Marshall V Williams, Henry K Wong
1Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Medical Center, The Ohio State University, Columbus, OH, USA.
Abstract:
Psoriasis vulgaris is a chronic, immune-mediated inflammatory skin disease associated with complex genetic susceptibility. Although the hallmark of psoriasis is characterized by cutaneous inflammation and keratinocyte hyperproliferation, recent studies show that the pathologic features observed in psoriasis arises as a result of innate and adaptive immune activation in genetically prone individuals. Studies focused on the microenvironment in the skin of psoriasis lesions have revealed novel cellular and cytokine abnormalities of the immune system. One pathway important is the role of the T(H)17/IL-17 dysregulation. The recent development of biologics that target the IL-17 cytokine pathway has confirmed the importance of T(H)17 and IL-17 homeostasis in the skin and yielded potent therapies in the treatment of psoriasis, and potentially other autoimmune diseases.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
EPS and iPS Cells in Disease Research
iPS Cell Differentiation
The JAK-STAT Signaling Pathway